BIONPHARMA, INC. Email Format

Pharmaceutical ManufacturingNew York, United States11-50 Employees

BIONPHARMA, INC. is a pharmaceutical manufacturing company located in Florida, New York, at 1751 State Route 17A, with 11 to 50 employees. The company develops and manufactures pharmaceutical products and has engaged in manufacturing arrangements with CoreRx, including the 2019 launch of Clobazam Suspension, described as the first US FDA-approved product to be developed and commercially manufactured by CoreRx. In 2018, Bionpharma invested in Corerxpharma, and in 2022 the company filed a suit against Corerxpharma to ensure continued delivery of enalapril maleate oral solution under their agreement. In September 2024, Bionpharma issued a voluntary nationwide recall of Atovaquone Oral Suspension due to bacterial contamination. Public records indicate revenue in the range of $25 million to $50 million and funding of $6.5 million.

Get verified BIONPHARMA, INC. emails free

Company overview Employee directory